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Quiescent hair follicle (HF) bulge stem cells (SCs)
differentiate to early progenitor (EP) hair germ (HG)
cells, which divide to produce transit-amplifying
matrix cells. EPs can revert to SCs upon injury, but
whether this dedifferentiation occurs in normal HF
homeostasis (hair cycle) and the mechanisms regu-
lating both differentiation and dedifferentiation are
unclear. Here, we use lineage tracing, gain of func-
tion, transcriptional profiling, and functional assays
to examine the role of observed endogenous Runx1
level changes in the hair cycle. We find that forced
Runx1 expression induces hair degeneration (cata-
gen) and simultaneously promotes changes in the
quiescent bulge SC transcriptome toward a cell state
resembling the EP HG fate. This cell-state transition
is functionally reversible. We propose that SC differ-
entiation and dedifferentiation are likely to occur dur-
ing normal HF degeneration and niche restructuring
in response to changes in endogenous Runx1 levels
associated with SC location with respect to the
niche.
INTRODUCTION
Mammalian development and adult homeostasis are generally
modeled as irreversible transitions between different cell states
(Waddington, 1957). Dedifferentiation can be achieved by
nuclear transfer or forced expression of master transcription
factors (Pournasr et al., 2011). Germline transit-amplifying (TA)
cells revert to stem cells (SCs) in the adult mouse and fly testis
(Simons and Clevers, 2011; Spradling et al., 2011). In mammals,
somatic TA cells, and sometimes even terminally differentiated
lineages (TDL), can dedifferentiate to SCs in injury or cancer
(Porrello et al., 2011; Schwitalla et al., 2013; Yanger et al.,
2013). However, within normal uninjured somaticmammalian tis-
sues, it is unclear to what extent distinctmolecular and functional
cell states may be reversible.CThe adult hair follicle (HF) is composed largely of epithelial cells
that form: (1) a permanent region (bulge) housing the HF SCs; (2)
the temporary region (bulb) containing TA cells (matrix) and the
TDL (inner root sheath [IRS] and hair core/shaft; Blanpain,
2010). The outermost root sheath (ORS) is contiguous with
the bulge SC layer. The dermal papilla (DP) is a mesenchymal
signaling center at the base of the bulb important for SC activa-
tion. HFs undergo cyclic phases of morphological remodeling
known as the hair cycle (Blanpain, 2010). The hair-cycle phases
are growth (anagen) when the bulge generates a new bulb,
regression (catagen) when bulb cells die by apoptosis, and rest
(telogen) when the bulge is quiescent (Mu¨ller-Ro¨ver et al., 2001).
In telogen, the bulb is replaced by the HG, which arises from
quiescent bulge cells (Ito et al., 2004; Zhang et al., 2009). The
HG fate is distinct from matrix and bulge fates, as shown by
gene expression (Greco et al., 2009). Moreover, HG cells prolif-
erate rapidly and then are lost from the dish (Greco et al.,
2009), and at least the late-stage HG cells arising directly from
bulge cells that migrate at telogen do not self-renew (Zhang
et al., 2009). Thus, the HG acts as an ‘‘early progenitor’’ (EP),
defined here as the first step of a bulge SC embarked on the
path of differentiation toward a TA matrix cell. Bulge SCs self-
renew at anagen by rare, symmetric divisions with respect to
the basement membrane (Zhang et al., 2009, 2010).
Some of the ORS cells that migrated from the bulge at late
anagen/early catagen remain below the bulge to eventually
make a ‘‘new’’ HG and some move up to form a ‘‘new’’ bulge
(Hsu et al., 2011). Importantly, it is not known whether the bulge
SCs displaced into the ORS simply change location or actually
differentiate into HGcells and then dedifferentiate upon returning
to the new bulge. It is known that, in response to injury, such as
hair plucking or LASER ablation, hair germ (HG) cells can dedif-
ferentiate to bulge SCs (Ito et al., 2004; Rompolas et al., 2013).
Whether this plasticity of fate is employed during normal hair
homeostasis, the significance of a putative flexibility in cell fate
in the absence of injury and a potential molecular mechanism
remain a mystery.
Previously we showed that Runx1, a transcription factor from
the Runt family (Blyth et al., 2005) is highly expressed in HG cells
and is essential for their activation/proliferation and subsequent
anagen onset (Hoi et al., 2010; Lee et al., 2013; Osorio et al.,ell Reports 6, 499–513, February 13, 2014 ª2014 The Authors 499
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2008; Scheitz et al., 2012). Runx1 is even more highly expressed
in the epithelial strand at late catagen (Osorio et al., 2008), sug-
gesting a possible role at this stage of the hair cycle.
Here, we provide experimental evidence suggesting that in-
crease in endogenous Runx1 levels during normal catagen has
a dual function: (1) to induce degeneration of TA and TDL line-
ages and execute catagen, and (2) to promote a reversible differ-
entiation of bulge SCs to HG EPs in the bulge cells that migrate
into the ORS (Figure 1A; Hsu et al., 2011). This reversibility may
ensure a proper balance between SC and EP populations during
niche restructuring in normal tissue homeostasis.
RESULTS
ORS Cells that Once Expressed Runx1 Contribute to
Both ‘‘New’’ Bulge and Hair-Germ Formation
Skin sections stained for endogenous Runx1 and CD34 (a bulge
SC marker) showed that Runx1 became detectable in CD34+
ORS cells just below the bulge by catagen II (Figure 1B). Based
on location and CD34 expression, this ORS region must contain
the migrated ‘‘old’’ bulge cells previously traced via H2B-GFP
and Lgr5-CreER (Hsu et al., 2011). CD34 levels were generally
higher in the old bulge than the ORS just below the bulge,
whereas Runx1 showed the opposite trend (Figure 1B). At cata-
gen VIII, the forming new bulge initially showed high Runx1/low
CD34 levels but switched to lowRunx1/high CD34 by the second
telogen. These data suggest that quiescent bulge cells that have
migrated into the ORS upregulate Runx1 at early catagen. By the
second telogen, if they become ‘‘new’’ bulge cells, they downre-
gulate Runx1, and if they become HG, they keep Runx1.
To test this, we marked Runx1+ ORS cells at early second
catagen and traced their lineage. Runx1-CreER;Rosa26RLacZ
adult mice were injected with tamoxifen (TM) for 4 days starting
at the sixth day after their skin turned from pink to black, indica-
tive of anagen (PD32; Figure 1C). We used thick, frozen skin
sections that encompass full HFs (90 mm for catagen and
60 mm for telogen; Figures 1C–1I). We scored the compartments
of each HF as positive or negative for LacZ+ cells, irrespective of
the total number of LacZ+ cells in the compartment, to rule out
proliferation effects.
Two days after the last TM injection (catagen; 2-day chase),
we quantified the initial labeling of Runx1-expressing cells and
found LacZ+ cells in >95% of HFs, in a pattern expected from
endogenous Runx1 expression (Figures 1D and 1H). In this
stage, endogenous Runx1 is expressed weakly in the bulge,
stronger in the ORS, and strongest in bulb cells including the
differentiated lineages (Figures 1B and S1A) and also in theFigure 1. Runx1+ Cells in the ORS at Catagen Generate New Bulge an
(A) Cartoon representation of cellular dynamics in the hair follicle shows the bulge
which survive apoptosis and return upward to form the new bulge and the HG.
(B) Skin sections stained for Runx1 and bulge SC marker CD34 show cells in th
Regions of theORSwith Runx1/CD34 overlap are enlarged in the upper right corne
ORS cells that lost contact with the inner layer. The ORS on the bulge side is ma
(C) Scheme of tamoxifen (TM) injection to genetically label and trace Runx1-exp
(D and E) Thick sections encompassing full hair follicles (HFs) stained with X-Ga
(F and G) Same as (D) but in thin sections counterstained with hematoxylin to de
(H and I) Counts of LacZ+ HFs with distribution of label in each compartment. Fo
Error bars were calculated as SD using Excel.
Cinfundibulum (Inf) cells (Scheitz et al., 2012). About 60% of
HFs showed LacZ+ cells in the IRS (a terminally differentiated
lineage TDL), and >90% of HFs showed LacZ+ cells in the
hair shaft/core (another TDL) and Inf (Figure 1D). None of these
lineages are expected to contribute normally to bulge SCs (Blan-
pain, 2010; Jaks et al., 2010) and HG regeneration (Greco et al.,
2009; Hsu et al., 2011).
The lineages expected to contribute to the ‘‘new’’ bulge and
HGare the ‘‘old’’ bulge andORS (Hsu et al., 2011), which showed
LacZ+ cells in 3% and 30% of all HFs, respectively, at 2-day
chase (Figures 1D, 1H, and S1B). Therefore, if Runx1-expressing
cells of the ORS at early first catagen contribute to the ‘‘new’’
bulge and HG, we expected that, after 10-day chase (second
telogen), a maximum of 33% of HFs would contain LacZ+ cells
in the ‘‘new’’ bulge and HG. This appears to be the case for HG,
because we found30%of HFswith LacZ+ cells in the HG at 10-
day chase (Figures 1E, 1F, and 1I).
Surprisingly, 80% of HFs were labeled in the ‘‘new’’ bulge at
10-day chase, suggesting additional contribution from other HF
compartments besides the ORS and ‘‘old’’ bulge (Figure 1I,
left). The bulge has two layers: the outer layer containing SCs
and the inner layer serving as the SC niche (Hsu et al., 2011). To
distinguish these, we analyzed thin (20 mm) sections, and indeed,
we found that only 20% of HFs in thin sections (corresponding
to30%of full HFs in thick sections) had LacZ+ cells in the outer-
bulge SC layer (Figures 1F and 1I, right), as expected from their
known origin in the ORS. These data confirm that, in addition to
contribution to HG, Runx1+ ORS cells contribute to the new
bulge. LacZ+ cells were present in the inner bulge in 50% of
HF in thin sections, which corresponds to 80% of full HFs in
thick (60 mm) sections (Figures 1F, 1G, and 1I, right panel), the
inner-layer LacZ+ cells most likely originated in Runx1+ HF TDL.
Moreover, additional data suggest that Runx1+ORS cells also
contribute to new bulge and germ in the first telogen (Figures
S1C and S1D), indicating that the same reorganization of the
SC niche might take place repeatedly during homeostasis.
Endogenous Runx1 Expression Is Downregulated in the
Hair Germ as It Begins Proliferation to Make the Matrix
at Anagen and Upregulated in Apoptotic Matrix Cells
These data raised the possibility that Runx1 upregulation in the
migrated bulge cells in early catagen ORS that act as precursors
of the HG may promote a bulge-fate transition toward HG cells.
Conversely, Runx1 downregulation in the ORS cells that returned
to the ‘‘new’’ bulge may revert them to a bulge fate. To further
investigate this, we first extended our previously reported analysis
of Runx1 expression (Osorio et al., 2008) in bulge SC, HG EP, andd Hair-Germ Cells
SCs displaced into the outer root sheath (ORS) at late anagen/early catagen,
e ORS with low CD34 and high Runx1 expression starting at catagen II to III.
r (white box). Note that Runx1 is upregulated in themost bulge-proximal CD34+
de of cells placed immediately right of the dotted yellow lines.
ressing cells from early catagen to telogen.
l to detect LacZ+ cells.
lineate the inner and the outer bulge layers.
r abbreviations, see (A).
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Figure 2. Transgenic Mouse to Model Runx1 Dynamic Expression Levels throughout the Hair Cycle
(A) Quantification of endogenous Runx1 levels throughout the hair cycle using immunofluorescence microscopy. See also Figures S1A, S1A0, and S1B. Data in
purple represent the Runx1 levels quantified in the transgenic mouse model described in (G)–(J). a.u., arbitrary units.
(B, D, and E) Skin sections stained for endogenous Runx1 and CD34 show abrupt downregulation of Runx1 in the transition from the hair germ (HG) to the matrix
(Mx) at anagen followed by upregulation in matrix and lower bulb cells at catagen.
(legend continued on next page)
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matrixTAcell compartments throughout thehair cycle.Quantifica-
tionofRunx1proteinby immunostaining revealedstrikingchanges
in levels in different compartments (Figures 2A, S1A, and S1A0).
In the bulge, Runx1 protein levels are generally low (Figure 2A),
although necessary for normal bulge proliferation at anagen (Hoi
et al., 2010). The mRNA level is higher in dividing bulge-sorted
cells compared to nondividing bulge-sorted cells (Figure S2A,
two asterisks). Bulge cells migrated in the upper ORS at catagen
(Figures 1B and 2A) and, at the bulge/HG junction at telogen, ex-
press higher Runx1 protein levels (Osorio et al., 2008; Figure 2B).
In the HG, Runx1 is necessary for proliferation presumably by
downregulating cyclin-dependent kinase inhibitors (Hoi et al.,
2010; Lee et al., 2013; Osorio et al., 2008). Thus, we expected
that Runx1 would remain high in dividing HG cells at anagen
onset. Surprisingly, someHGcells with reducedH2B-GFP reten-
tion after 3-day doxycycline chase on TRE-H2BGFP;K5-tTA
mice at anagen onset, indicative of one to two divisions (Zhang
et al., 2009), showed reduced Runx1 protein and mRNA levels
(Figures 2C, arrows, and S2A, one asterisk). The expression pro-
files of these divided HG cells at anagen onset resemble the
matrix signature (Zhang et al., 2009), whereas the profiles of
quiescent HG cells at telogen (prior to divisions) resemble the
bulge (Greco et al., 2009). These observations suggest that, as
HG EPs begin to divide, they rapidly transit to matrix TA cells
and that Runx1 levels quickly decrease during this transition.
In the matrix, Runx1 protein remained undetectable throughout
anagen but became suddenly high in early catagen, when these
cells are known to undergo apoptosis (Figures 2A, 2D, 2E, S1A,
and S1A0). Runx1 levels in matrix cells increased even more as
catagenprogressedand reached its highest level in the regressing
apoptotic epithelial strand in late catagen (Figures 1B, 2A, S1A,
and S1A0). This provides a strong correlation between Runx1
levels of endogenous expression and apoptosis in the matrix.
The dynamics of endogenous Runx1 expression are summa-
rized in Figure 2F.
Generation of Tet-Inducible Transgenic Mice to
Modulate Runx1 Expression Levels
To directly test a potential role of observed endogenous Runx1
level changes in the hair cycle, we generated tetracycline-induc-
ible transgenic mice. The K14-rtTA construct (‘‘on’’ in skin and
other epithelia) will drive a newly generated TRE-mycRunx1 allele
(see Experimental Procedures; Supplemental Information) upon
doxycycline (doxy) induction. TheK14-rtTAmicepreviously drove
physiologically meaningful levels of another transcription factor
in the skin (Nguyen et al., 2006). Within 4–6 hr of doxy induction,
mycRunx1 expression would turn on, whereas withdrawing
doxy would revert expression to undetectable levels (Figure 2G).(C) Skin sections from TRE-H2BGFP;K5-tTAmice doxy chased (PD18–PD21) sho
(arrowheads indicate undivided cells, whereas arrows point to cells that divid
downregulation in divided HG cells. See also Figure S2A for mRNA levels in divid
(F) Cartoon summarizing Runx1 expression levels in different compartments thro
(G) Scheme of transient mycRunx1 induction and withdrawal in transgenic mice
(H) Mice induced for 9 days with doxy are small and die within a few days. mTG
(I) Skin sections from WT and Runx1iTG at stages indicated stained for mycRunx
(J) Skin sections stained side by side for Runx1 and photographed at the same ex
endogenous levels in the forming IRS quantified in (A) and Figure S1A0. See Figu
Error bars were calculated as SD using Excel.
CAs expected, the doxy-induced TRE-mycRunx1;K14-rTA dou-
ble transgenic mice (Figures 2H and S2B) turned on mycRunx1
nuclear expression, as shown by anti-myc staining (Figures 2I
and S2C). Withdrawing doxy food shut down mycRunx1 expres-
sion by PD49 (Figure 2I, right). Two TRE-mycRunx1 mouse lines
proved fully inducible by staining of different body regions (not
shown), and we refer to them here as Runx1iTG. Twomouse lines
showed mycRunx1 expression in skin patches throughout the
mouse back skin, andwe refer to themhere asmosaic Runx1mTG
lines. Double transgenic (TRE-MycRunx1;K14-rtTA) littermates
without doxy and all single transgenic littermates showed no
detectable staining andare designated aswild-type (WT) (Figures
2I andS2C). Runx1iTGmicebegan losingweight 6 days after doxy
induction (Figure 2H) and died within 9–12 days, but they recov-
ered ifwewithdrewdoxy foodafter5daysof induction (Figure6B).
Runx1mTG mice were viable, and we used them for long-term
studies along with skin transplants from Runx1iTG (Figures 2H,
4B, and 4C). All the experiments shown here were performed at
least twicewith nmouseR 2 to 3 of each genotype per experiment.
To achieve near-physiological Runx1 protein levels and avoid
artifacts of excessively high expression, we chose the doxy con-
centration of several tested (Experimental Procedures) that gave
us consistently detectable mycRunx1 expression in the bulge,
which appeared comparable to endogenous Runx1 expression
in the IRS, HG, and early catagen matrix (Figure 2J, quantified
in Figures 2A and S1A0).
Runx1 Is Insufficient for Anagen Onset but Sufficient to
Induce Catagen
Runx1 is necessary for HG activation and proliferation and for
timely anagen onset (Osorio et al., 2008), so we tested whether
forced expression of Runx1 was sufficient to induce anagen.
We induced Runx1iTG during the second telogen, a period of pro-
longed quiescence inmostmouse strains, but found no evidence
of anagen onset, as shown by normal telogen morphology (Fig-
ures 3A and 3F, blue) and lack of bromodeoxyuridine (BrdU)
staining in Runx1iTG skin (Figure S2D). These resultsmay suggest
that the presence of inductive anagen signals, not present in the
skin at second telogen,might be required in addition to Runx1 for
normal anagen onset. Forced Runx1 expression in second telo-
gen did, however, result in CD34 downregulation (Figure S4C).
We next induced mycRunx1 elevation in the short and syn-
chronous first quiescence period (PD17PD20) where the ana-
gen proliferative signals arise shortly after (PD20PD21). We
doxy-fed Runx1iTG mice for 4 to 5 days starting in quiescence
at PD17 or PD19 and examined the HF morphology in skin sec-
tions stained with hematoxylin and eosin (H&E) (Figures 3B and
3F, red). In this Fvb mouse strain, WT skin was already at almostwcells with an apparent inverse correlation between H2BGFP and Runx1 levels
ed and diluted H2BGFP during the 3-day chase). Note the apparent Runx1
ed versus undivided cells isolated by FACS.
ughout the hair cycle.
responsive to doxy.
mice are normal size and survive.
1 and CD34.
posure. Note comparable transgenic Runx1 levels in the bulge (Bu) and HG to
re 1A for abbreviations.
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Figure 3. Runx1 Expression Is Sufficient for Catagen Implementation in Bulb Cells but Requires Additional Anagen-Inductive Signals to
Promote Stem Cell Proliferation
(A–D) Hematoxylin and eosin (H&E)-stained skin sections from doxy-induced mice at stages indicated. WT were littermate controls. Note normal telogen
morphology in Runx1iTG and WT in (A). Note Runx1iTG HFs with smaller bulb and lack of hair shaft indicative of earlier anagen, with a DP unenclosed by the
epithelial cells in (B) followed by return to telogen with a single hair shaft (*) in (C). (D) HFs in the 16-day induced mosaic Runx1mTG skin showed variable hair-cycle
stages (dotted rectangles).
(E) Corresponding stages are shown, with Runx1 antibody (Ab) staining (green). Note endogenous Runx1 expression pattern in anagen HF (top) and
transgenic pattern (with a positive Bu and interfollicular epidermis) in late catagen/telogen HF (bottom). Note the presence of two hair shafts (*) indicating this
(legend continued on next page)
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full anagen by PD21, showing a developed bulb and a newly
forming hair shaft (Figure 3B, top). Contrary to our expectation
that anagen would be accelerated, Runx1iTG HFs were behind
in anagen progression by 4 days of induction relative to controls
(Figure 3B, bottom) and prematurely returned to telogen without
producing a new hair shaft by 9 days (Figures 3C and 3F, green).
Mosaic Runx1mTG induced for 16 days at PD19 showed an
abnormal mixture of different HF-cycle stages (Figures 3D and
3F, #). HFs at morphological stages comparable with WT litter-
mates (anagen) showed the endogenous Runx1 staining pattern
(Figure 3E, top). In contrast, HFs that expressed Runx1 at
elevated levels in a transgenic pattern were found prematurely
at catagen or the second telogen, as indicated by HF mor-
phology and the presence of two hair shafts (Figure 3E, bottom).
We attribute this phenotype to the misexpression of Runx1, not
only in the quiescent bulge but also in the matrix and the lower
ORS, where endogenous Runx1 is normally not expressed dur-
ing anagen until these cells begin apoptosis at catagen onset.
Runx1iTG induction for 5 and 9 days in early- and midanagen
(PD21 and PD23) resulted in catagen morphology (Figure 3F,
black, 3G, right panel, and S3C). This suggested that Runx1 is
sufficient to induce catagen at any stage of anagen and may
explain why endogenous Runx1 is suddenly turned on at its
highest levels in the lower bulb in catagen.
Terminaldifferentiationmarkersanalysis (GATA3 for the IRSand
AE13 for the hair shaft) revealed complete lack of TDL in Runx1iTG
HFs induced at PD17/PD19 (Figure S3A). Apoptosis (caspase-3)
and proliferation (BrdU injection 2 hr prior to sacrifice) analysis
revealed massive apoptosis in the matrix (Figure 3G and S3C).
In the bulge, mycRunx1 downregulated CD34 (Figures 3J–3L
and S4) and also increased proliferation (Figures 3H and S3B);
the latter we expected would occur in conjunction with inductive
proliferative signals present in skin at the first (short) telogen.
CD34 reduction was cell autonomous, as suggested by mosaic
analysis (Figure 3K), which ruled out a hair-cycle stage effect
of Runx1 on bulge-marker CD34 expression. Quantification of
BrdU, Ki67, and caspase-3 for the PD17–PD21 induction is pro-
vided in Figure 3I. Note that the difference in hair-cycle stage
observed here cannot account for the differences in BrdU incor-
poration. This result implied that Runx1 elevation might promote
the bulge-cell transition to a HG-like cell state as defined by
being CD34 and more responsive to proliferative anagen-
inducing signals present in the skin at the first telogen.
To distinguish direct versus systemic effects, we induced
mycRunx1 expression in TRE-mycRunx1;K14-rtTA keratinocyte
cell lines and in transiently transfected CD34+/a6+ bulge and
CD34/a6+ nonbulge sorted cultured cells (Figures S3D–S3F).
Runx1 elevation resulted in a brief burst of BrdU incorporation,HF had been through at least a portion of the first adult anagen. White asterisk
new shaft.
(F) Summary of short-term doxy induction and results.
(G–I) Staining formarkers indicated and quantified in (I) reveal increased BrdU inco
(Mx) and bulb.
(J and K) Skin sections fromRunx1iTG and Runx1mTGmice show downregulation o
in (K), correlating with lack of CD34 expression.
(L) FACS histogram shows overlay of four populations isolated from Runx1iTG a
several-fold decrease in CD34 level in CD34+/a6+ Runx1iTG bulge cells compare
Error bars were calculated as SD using Excel.
Cfollowed by a plunge below WT control levels, accompanied
by increased apoptosis (Figures S3E and S3F). These data
demonstrate a cell-autonomous effect on apoptosis and prolifer-
ation of keratinocytes by high Runx1 levels.
Long-TermFunctional Assays Show that StemCellswith
Continuous High Runx1 Expression Switch to a Short-
Lived Progenitor Behavior
Next, we performed long-term functional assays to ask if
mycRunx1-expressing bulge cells continue to behave in vivo
and in vitro like long-lived SCs or switch to a short-lived EP cell
behavior.
We employed both skin grafts of the Runx1iTG mice onto nude
mice to avoid lethality after 9-day induction and the two
Runx1mTG mouse lines, which appeared healthy in long-term
induction. Transplanted nude mice were fed doxy chow at the
equivalent PD19, after shaving the original hair coat, which
permanently arrested new hair coat growth (Figures 4A and
4B). Both Runx1mTG mice and grafted Runx1iTG skin began to
lose the hair coat (in patches for Runx1mTG) within a few weeks
of induction and remained bald for the entire 1-year duration
of the experiment (Figures 4A–4C). Upon inspection of sections
from the long-term Runx1iTG skin, rare degenerated HF rem-
nants were detected in Runx1iTG dermis, which showed epithe-
lial K14 expression but lacked the SC marker CD34 (Figure 4D).
Thus, long-term expression of mycRunx1 in the HF in vivo
inhibited the long-lived regenerative potential of bulge SCs and
resulted in complete loss of the hair follicle, thereby causing a
behavior expected of short-lived progenitors.
Next, we turned to colony formation assays (CFAs), an in vitro
functional measure of self-renewal ability (Blanpain, 2010). Bulge
SCs are slow in seeding colonies, but then they expand contin-
uously whereas HG cells are fast in seeding colonies but shortly
exhaust their growth potential (Greco et al., 2009). Primary kera-
tinocytes isolated from Runx1iTG skin of 5-day doxy-fed adult
mice (PD17–PD22) displayed rapid initial proliferation with
increased colony number and size, followed in 40 days by
exhaustion and cell senescence, being mostly lost from the
dish by 60 days (Figures 4E–4G and S6A–S6C), therefore
behaving as short-lived HG EPs. As expected, WT cells showed
the typical growth pattern of adult skin keratinocytes exhibited
by long-lived SCs (Figures 4E–4G and S6A–S6C).
High Runx1 Expression in Bulge Cells Promotes a
Massive Change in Gene-Expression Signature that
Largely Resembles the Early Progenitor Hair Germ
Next, we analyzed the gene expression changes that occur in
bulge cells upon mycRunx1 induction to further test if the bulgemarks the old shaft (club hair) in the old bulge, and yellow asterisk marks the
rporation (2 hr pulse) in Runx1iTG bulge (Bu) andmassive apoptosis in thematrix
f CD34 by immunostaining. Note mosaic expression of mycRunx1 in bulge (Bu)
nd WT littermate mouse skin when bulge SCs were at catagen/telogen. Note
d to WT bulge. See also Figures S3 and S4.
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Figure 4. Long-Term Runx1 Induction in Bulge SCs Confer a Short-Lived Progenitor Cell Behavior Both In Vivo and In Vitro
(A) Grafted newborn Runx1iTG skin onto nude mice, to bypass lethality of Runx1 induction, prior to doxy feeding at the equivalent PD19.
(B) Grafted areas on nude mice at times postinduction as indicated. Note permanent hair loss in Runx1iTG skin.
(C) Runx1mTG mice induced with doxy for >3 months show permanent hair loss in a patchy manner, as expected from mosaic expression of Runx1.
(D) Skin sections from (B) sectioned and stained as indicated show lack of HFs in Runx1iTG skin. Circles show rare remnants of HF cells, which are stained positive
for mycRunx1 and K14, but are negative for the SC marker CD34. MycRunx1 staining shows higher dermal background in Runx1iTG than WT, possibly due to
increased cellularity in the former.
(E–G) Keratinocytes isolated from PD17–PD22 doxy-treated mice were plated on irradiated mouse embryonic fibroblast in low Ca2+ E medium. Colonies were
counted every week; representative phase contrast images are shown in (E) and the overall counts are shown in (G). See also Figures S6A and S6B. Note
diminished colony size and flat-cell morphology indicative of senescence at 60 days in Runx1iTG cells. (F) Endogenous SA-b-Gal staining indicates senescence of
Runx1iTG cells by 60 days. See also Figure S6C.
Error bars were calculated as SD using Excel.
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cells are converting to a HG expression signature. Supporting
this, themRNA of CD34 and several other known HF SCmarkers
was downregulated in the Runx1iTG CD34+/a6-integrin+ bulge
cells, sorted within 1–5 days of doxy induction (Figures 5A
and 5A0).
To examine global gene-expression changes we turned to
Affymetrix microarrays. K15-EGFP mice (Morris et al., 2004)
showed bright GFP expression in the HG and in some bulge cells
at telogen (Figures 5B and 5C). Runx1iTG;K15-EGFP mice
and WT;K15-EGFP control littermates were doxy-induced at
PD19 for 1 day, and their skin cells were isolated by fluores-
cence-activated cell sorting (FACS) as CD34+/a6+ bulge cells
irrespective of GFP expression and as CD34/a6+/GFP+ HG
cells (Figures 5B and 5C). We examined skin from six different
regions of the body to ensure telogen morphology and quies-
cence of bulge cells in all skin samples used for microarrays
(Figures S5A and S5B). Affymetrix microarrays and GeneSpring
software analysis revealed that over 2,500 probe sets (2,500
genes) changed expression in Runx1iTG bulge relative to WT
bulge cells, suggesting profound and rapid changes in the
molecular signature of quiescent bulge cells upon Runx1 eleva-
tion after only 1 day (Tables S1 and S2; Gene Expression
Omnibus [GEO] database GSE53077 [National Center for
Biotechnology Information number 16928442]).
Next, we compared the WT databases and extracted a bulge
(4,453 probe sets) and a HG (2,556 probe sets) signature, as
genes increased by >23 in one population versus the other
(Tables S1 and S2). We used previously published databases
to define the matrix signature, which was different from both
the HG and bulge (Greco et al., 2009; Lien et al., 2011). Consis-
tent with the known role of Runx1 in both activating and repres-
sing transcription, 1,527 probe sets were downregulated in
CD34+/a6+ Runx1iTG bulge compared to WT bulge cells and
1,097 probe sets were upregulated (Figure 5D). Importantly,
the ‘‘bulge signature genes’’ were largely downregulated
whereas the ‘‘HG signature genes’’ were largely upregulated in
Runx1iTG bulge compared to WT bulge (Figures 5E and S5C).
A comparison with the matrix signature did not show ameaning-
ful correlation with changing Runx1 levels (Figure 5E, right).
These data strongly suggest that short-term induction of high
Runx1 levels in quiescent bulge cells turns the molecular signa-
ture of bulge cells into that of a cell-state resembling HG cells.
To understand howRunx1might act in quiescent bulge cells to
promote a HG fate, we examined known pathways that regulate
hair growth and homeostasis (Lee and Tumbar, 2012). However,
these pathways were represented broadly among Runx1 target
genes anddid not suggest a singlemodeof action in this fate con-
version (TableS2).Consistentwitha roleofRunx1asmaster regu-
lator of many pathways in a fate switch, a number of chromatin-
remodeling factors, which are generally known to promote and
stabilize cell-fate transitions, changed their mRNA expression
(Figure S5D). The overrepresented Gene Ontology (GO) cate-
gories among downregulated bulge-signature genes were signal
transduction, development, differentiation, cell motility, and cell
adhesion (Figure 5F; Table S3; Supplemental Information).
Conversely, theGOcategories overrepresented among the upre-
gulated HG-signature genes were all implicated in metabolism
(Figure5G;TableS3;Supplemental Information [seeDiscussion]).CThe HG-like Cell State Induced by High Runx1 Levels in
Bulge SCs Is Reversible
All the data so far suggest that endogenous Runx1 expressed in
bulge SCsmigrated in theORSat catagenmay promote the early
steps of SC differentiation toward early progenitor HG fate.
Because some of these Runx1+ ORS cells return to the ‘‘new’’
bulge, lose Runx1 expression, and regain CD34, we wondered
whether the HG-like state induced by Runx1 in ORS cells might
be functionally reversible. To test this, we doxy-fed Runx1iTG
mice for 5 days starting at PD17 (or PD21) to express mycRunx1
and induce the HG-like cell state in bulge cells, followed by doxy
withdrawal (Figure 6A). These mice are now designated as
Runx1iTG, withdrawn. After >23 days of doxy food withdrawal,
mycRunx1 expression was no longer detectable (Figure 2I).
Whereas bulge CD34 expression is lost upon 1–5 days of
mycRunx1 expression (Figures 3J–3L, S4A, and S4B), it was fully
restored in Runx1iTG, withdrawn mice by PD49 (Figure 2I).
We then monitored hair growth, lineage contribution, and cell-
culture behavior to examine if bulge cells that experienced tran-
sient high Runx1 levels can return to a SC phenotype (Figure 6A).
In marked contrast to Runx1mTG mice or skin grafts from
Runx1iTG mice, in which long-term mycRunx1 expression led
to HF and SC loss, hair growth in Runx1iTG, withdrawnmice showed
a slight delay in the first anagen onset but then cycled normally
for two additional hair cycles (Figure 6B).
Next, we examined the lineage contribution of the WT and
Runx1iTG, withdrawn bulge SCs to verify that they self-renew and
differentiate in a similar manner, despite the transient Runx1
expression in the latter. Thus, we performed lineage-tracing
experiments using quadruple Runx1-CreER;Rosa26R-LacZ;
Runx1iTG (TRE-mycRunx1;K14-rtTA) transgenic mice. We first
marked bulge cells by TM injection at PD17 (catagen) and then
induced mycRunx1 expression by feeding mice doxy food at
PD21. Subsequent tracking of marked Runx1iTG, withdrawn bulge
SCs and their progeny showed no difference in LacZ+ cell distri-
bution and frequency within the bulge (indicating self-renewal) or
bulb (indicating differentiation) compared to WT bulge cells
(Figures 6C–6E and S7). Thus, the bulge SCs that had function-
ally behaved as HG cells after Runx1 level elevation reverted to
a normal SC behavior, self-renewing and differentiating over
long term at similar rates with the WT bulge cells upon doxy
withdrawal.
To further test the reversibility of the cell state induced by tran-
sient Runx1 expression in bulge SCs, we also performed in vitro
functional assays (Figure 6F). Keratinocytes isolated from PD79
Runx1iTG, withdrawn mice (but not earlier) showed normal SC-like
patterns of colony formation, like the WT controls (Figure 6G).
In contrast, if we added doxy to Runx1iTG, withdrawn cells in cul-
ture, they behaved again as early progenitor HG-like cells (Fig-
ure 6G; iTG; withdrawn+doxy). All these functional assay data
were consistent with reversion of HG-like fate induced by
Runx1 to a bulge SC fate upon Runx1 withdrawal.
DISCUSSION
With this work, we examined the role of changing endogenous
Runx1 levels throughout the hair cycle, which appears to be
specialized in different HF compartments. We propose thatell Reports 6, 499–513, February 13, 2014 ª2014 The Authors 507
Figure 5. Runx1 Initiates a Hair-Germ, Early-Progenitor Fate in Bulge Cells
(A and A’) Quantitative RT-PCR (qRT-PCR) of sorted bulge cells show robust downregulation of several bulge stem cell markers tested.
(B) Skin sections from K15-EGFP;Runx1iTG mice at PD20 show telogen morphology and GFP expression in the HG and in some bulge (Bu) cells.
(C) FACS dot plot shows sorting gates to isolate bulge (as CD34+/a6+/GFP+/ cells) and HG cells as (CD34/ a6+/GFP+). The cutoff for HG GFP was for the
brightest 1/3 of the cells to avoid potential contamination from dimmer cells occasionally found in epidermis and sebaceous gland (not shown).
(D) Microarray analysis of wild-type (WT) and iTG-bulge (Bu) and hair-germ (HG)-sorted populations; shown are number and probes, which decrease or increase
among each paired comparison.
(legend continued on next page)
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Runx1 acts as a determining factor in the transition from bulge
SCs to the early progenitor HG cell state. This state induced
by Runx1 in quiescence is reversible and represents a meta-
stable intermediate in the SC to TA cell-fate transition (Figure 7).
Moreover, we found that Runx1 is sufficient for catagen induc-
tion in full anagen HF.
Runx1 Expression in Bulge Cells Promotes the
Transition toward the Hair-Germ Fate
An important outcome of this study is that mycRunx1 elevation in
bulge SCs induces significant changes in gene expression and
cell behavior that closely resemble the HG EP fate. Previously,
our candidate approach revealed Wnt, Stat3, and p21 as regu-
lated downstream of Runx1 in the HF (Lee et al., 2013; Osorio
et al., 2011; Scheitz et al., 2012). Here, we show that Runx1
broadly regulates bulge expression of 2,500 genes that fit
multiple pathways, including global-chromatin-remodeling
factors. This is consistent with a probable role of Runx1 as one
of the master regulators that switch off the bulge signature and
on the HG gene signature. Moreover, whereas WT keratinocytes
behave as SCs in culture, the mycRunx1-expressing keratino-
cytes adopt rapid proliferation and short-lived behavior typical
of early progenitors, previously described forWTHGcells (Greco
et al., 2009). In vivo, bulge cells with mycRunx1 expression
initially proliferate faster in response to anagen signals but are
lost from the skin in long term, therefore also behaving essen-
tially as short-lived progenitors.
Previously, we have implicated Runx1 as a proliferation factor
in HG and bulge-cell activation at anagen onset by loss of
function studies (Osorio et al., 2008). Here, we carefully describe
endogenous Runx1 levels, which appear tightly coupled with
cell location relative to the bulge SC niche. Within the bulge,
low Runx1 levels are apparently needed for normal bulge SC
proliferation rates during anagen (Figure 7A; Hoi et al., 2010).
Quiescent SCs outside the niche in the ORS at catagen exhibit
elevated endogenous Runx1 levels that remain high as these
cells form theHGat telogen and then decrease again right at pro-
liferation onset as these HG cells become matrix TA cells (Fig-
ure 7B). Although Runx1 expression is necessary for HG and
bulge-cell activation/proliferation and for anagen onset (Osorio
et al., 2008), we find here by transgenic expression that it is
not sufficient. Based on all these data, we propose that Runx1
endogenous expression in the ORS at quiescence (catagen/tel-
ogen) in bulge SCs transitioning toward HG may prepare these
cells for overcoming their ‘‘slow-cycling’’ SC character, thus
becoming fit for rapid response to subsequent proliferation sig-
nals, as expected of HG cells. This ‘‘fitness’’ is perturbed in the
absence of Runx1, resulting in delay of SC activation.
Our gene-expression studies begin to reveal some of the
potential specific functions Runx1 may be performing during
the transition of bulge SC to the early progenitor HG. In partic-
ular, cell-adhesion genes are downregulated, suggesting that
Runx1 might promote bulge-cell release from the niche and(E) Comparison of bulge iTG/WT bymicroarrays shows changes in bulge (Bu), hair
and upregulation of HG signature in iTG bulge. The effect on matrix signature wa
(F and G) GO categories enriched among Runx1 targets in two selected gene su
qRT-PCR signals for each gene were normalized to GAPDH, and errors of exper
Cmigration down the basement membrane into the ORS. Consis-
tent with this interpretation, Runx1-deficient keratinocytes
display defects in cell migration (Osorio et al., 2011). Conversely,
HG signature genes preferentially upregulated by Runx1 in the
quiescent bulge cells are metabolic enzymes. We previously
showed that Runx1 promotes the G1/S transitions of the cell
cycle in skin keratinocytes (Hoi et al., 2010). Therefore, a poten-
tial involvement of Runx1 in cell growth during the G1 phase
in vivo, prior to divisions at anagen onset, may explain at least
in part how Runx1 might act in G0/G1 quiescence during cata-
gen to prepare HG cells for their subsequent proliferation at an-
agen onset. An interesting twist is that, even though ORS cells
downregulate Runx1 upon entering the ‘‘new’’ bulge, their tran-
sient endogenous Runx1 expression in the ORS may also pre-
pare them for the subsequent proliferation at anagen for proper
SC self-renewal. These aspects of Runx1 regulation will be sub-
ject of a future study.
In summary, all our data suggest that the role of endogenous
high Runx1 levels in ORS cells that migrated from the bulge
at catagen is to promote the early steps of their fate transition
toward the early progenitor HG.
Runx1 Expression in the Lower-Hair-Follicle Bulb Is
Sufficient to Implement Catagen
Despite the highest endogenous Runx1 expression in the
apoptotic bulb and epithelial strand at catagen (Figure 7E), our
previous knockout studies did not reveal a role of Runx1 at this
stage. Here, however, we show that early elevation of Runx1
can initiate apoptosis exclusively in those cells that would
normally express high levels of Runx1 just as they begin to un-
dergo apoptosis. Because the affected HFs progress through
catagen to a normally structured telogen, we propose that
expression of endogenous Runx1 is a normal trigger of
apoptosis at catagen. However, there must be a redundant sys-
tem(s) to trigger apoptosis in the absence of Runx1. Interestingly,
endogenous high Runx1 expression at catagen below the bulge
appears to conveniently couple the removal of the ‘‘used’’ matrix
TA and TDL cells with the differentiation of bulge SCs toward
supplying new HG early progenitors, making catagen an essen-
tial state cell-fate acquisition in HF.
Reversible Hair-Germ-like Cell State Induced by Runx1
in Quiescent Hair-Follicle Stem Cells during Normal
Homeostasis
Whereas previous work demonstrated that ‘‘old’’ bulge cells that
migrated into the upper ORS returned to the ‘‘new’’ bulge (Hsu
et al., 2011), experimental evidence supporting significant
functional and/or molecular changes during this journey outside
the niche was lacking. Here, we provide expression and lineage
tracing data demonstrating that the migrated bulge cells in the
upper ORS upregulate endogenous Runx1 and downregulate it
again when they return to the ‘‘new’’ bulge. Furthermore, we
find that Runx1 upregulation in bulge cells rapidly promotes a-germ (HG), andmatrix-gene signature. Note downregulation of bulge signature
s neutral. See also Figure S5C.
bsets, as indicated.
imental conditions were propagated to calculate SD.
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Figure 6. Bulge Stem Cell Fate Transition Induced by Runx1 Is Functionally Reversible
(A) Scheme of doxy induction and withdrawal to assess reversibility of Runx1-induced effects on bulge-cell function.
(B) Mice on doxy food (left) had hair on their lower backs gently removed to monitor hair growth without causing activation of growth by injury. They regrew hair
after doxy withdrawal (right) for three consecutive cycles (compare with Figure 4B).
(C) Skin sections from Runx1-CreER;Rosa26R;Runx1iTG mice injected with TM at PD17, doxy treated from PD21–PD26, and sacrificed at PD27 (left panel) show
localization of LacZ+ cells to the bulge. Middle and right panels show LacZ+ cells in the differentiated HF compartment (bulb) and in the SC compartment (Bu) at
the two subsequent anagen stages after TM injection.
(D and E) LacZ+ HF counts of images collected from all stages in (C) show similar patterns of LacZ contribution to HF regeneration in iTG and WT skin. See also
Figure S7.
(F) Scheme of doxy treatment and withdrawal for colony formation assays (CFA) to examine the growth potential (self-renewal ability) of cells that transiently
experienced mycRunx1 expression.
(G) CFA of cells from (F) show recovery of SC-like behavior in cells from mice in which doxy was withdrawn for several weeks after the initial 5 days of doxy
treatment (note iTGwithdrawn versus WT plots). Keratinocytes from these mice, cultured with doxy upon plating, displayed once again the behavior described
previously for the HG (rapid proliferation followed by death; see plots marked iTGwithdrawn +doxy). See also Figure S7.
Error bars were calculated as SD using Excel.cell state resembling the early progenitor HG (see the first
section of the Discussion) and that this effect is functionally
reversed when Runx1 is downregulated.510 Cell Reports 6, 499–513, February 13, 2014 ª2014 The AuthorsDedifferentiation of the HG to bulge cells was previously pro-
posed as a response to injury (hair plucking), although lineage-
tracing data are still missing (Ito et al., 2004), andwas also shown
Figure 7. Proposed Role of Changing Levels of Runx1 in Adult Hair-Follicle Homeostasis
(A) Low levels of Runx1 expression in bulge cells enhance self-renewal (Hoi et al., 2010).
(B) Runx1 upregulation in quiescent bulge cells found outside the niche results in early progenitor fate, a metastable and reversible state, that functions as an
intermediate between stem cells (bulge) and transit-amplifying cells (matrix).
(C) Inductive proliferation and differentiation signals cause the early progenitor to proliferate, downregulate Runx1, and fall down the hill of biological potential to a
more stable (irreversible) matrix TA cell fate.
(D) TA cells terminally differentiate to specific HF lineages. Relatively high Runx1 expression in one (IRS) of these lineages during anagen is shown in red.
(E) TDC/TA cells with high Runx1 expression undergo apoptosis and therefore are plotted at zero potential. The reversible fate change induced by Runx1 is based
on transgenic transient-expression experiments.to occur in response to injury by LASER ablation (Rompolas
et al., 2013). Our data suggest that differentiation and dedifferen-
tiation of bulge SCs are likely to occur naturally at catagen, dur-
ing the bulge SC journey outside the niche (old bulge) in the ORS
followed by a return (new bulge), when these traveling SCs expe-
rience changing endogenous Runx1 levels. Moreover, these SC
fate changes occur in the absence of cell division, because bulge
and upper- and mid-ORS cells are known to withdraw from the
cell cycle during this catagen/telogen period (Hsu et al., 2011).
This flexibility in fate may provide robustness to produce the
correct ratio of ‘‘new’’ bulge and ‘‘new’’ HG cells from a fixed
pool of quiescent ‘‘old’’ bulge cells to recreate the proper telogen
HF structure for the next regeneration cycle.
Lessons for Tissue Stem Cell Early Differentiation:
Quiescent Reversible Transition State
Our data fit a model for HF SC fate determination that follows
Ferrell’s theory proposed for early development fate transitions
(Ferrell, 2012), as an alternative to the irreversible fates
described by Waddington (1957). Specifically, the first step in
stem cell differentiation toward a progenitor cell may occur in
quiescence (catagen/telogen), when some SCs exit the niche
and become early progenitors (HG cells). The differentiation of
SCs to TA or progenitor cells would occur through a reversible
transition state, the ‘‘early progenitor,’’ conveniently represented
in the HF by an identifiable and sufficiently long-lived (although
still short-term) cell state, the HG. SC differentiation into early
progenitor cells is probably driven by upregulation of certain
fate determinants, of which Runx1 appears to be an early one
in the HF. The early progenitor transition state is metastable,
as it would either fall backward from the hill of biological potential
to remake SCs (when HG-like cells in ORS dedifferentiate to the
‘‘new’’ bulge) or fall forward to divide and make the TA cells
(differentiation of HG cells to matrix cells), which are more stable
cell states. Additional inductive proliferative signals (anagen pro-Cmoting) are also needed for the early progenitors to engage in
cell division and become TA cells (Figure 7F). The fate revers-
ibility is likely to cease upon cell division, as suggested in the
HF by the fact that dividing HG cells rapidly change to acquire
matrix TA characteristics upon one to two divisions (Zhang
et al., 2009), and matrix cells cannot make SCs, as shown by
lineage tracing (Greco et al., 2009).
Our proposed model in the HF, which implicates a reversible
transition cell state in quiescence mediating the SC to TA cell-
fate commitment, may provide new insight especially to the SC
systems that are more active or less synchronous than the HF,
where the steps of SC to TA cell-fate transition are difficult to
delineate and the EP transition state is very short-lived.
EXPERIMENTAL PROCEDURES
Mice
Mouse work followed Cornell Institutional Animal Care and Use Committee
guidelines. The c-Myc tag was inserted to the Runx1 N terminus in the
pcDNA3.1Runx1b (a gift from Nancy Speck), and the mycRunx1 fragment
was transferred to pTRE2 (Clontech) vector. Cornell Mouse Transgenic Core
Facility generated ten transgenic TRE-mycRunx1+ mice, which were tested
for inducibility by crossing with K14-rtTA mice (Nguyen et al., 2006) and
feedingmice with 20, 60, 200, and 1,000mg/kgmouse chow. The last concen-
tration was used in all subsequent experiments. We used TRE-H2BGFP;
K5-tTA for in vivo cell-division counting (Tumbar et al., 2004), Runx1-LacZ
mice for Runx1 expression studies (North et al., 2002), and Runx1-CreER
mice (Samokhvalov et al., 2007) crossed with Rosa26RLacZ mice (JAX)
for lineage tracing. Sequential crosses were performed to obtain quadruple
transgenic mice: Runx1-CreER;Rosa26LacZ;TRE-mycRunx1 (iTG, fully
inducible);K14-rtTA. For hair-germ and bulge cell sorting after 1-day doxy
induction at PD19, we crossed K15-EGFP mice (Morris et al., 2004) with
TRE-mycRunx1(iTG);K14-rtTA mice.
Microarrays
Sorted CD34+/a6+ (bulge) and CD34/a6+/GFP+ (hair germ) cells were used to
preparemRNA from two differentmice of each genotype and then subjected to
Affymetrix microarray assay (Cornell Core Facilities) followed by GeneSpringell Reports 6, 499–513, February 13, 2014 ª2014 The Authors 511
analysis. After excluding the probes with a signal value <100 or called absent,
genes designated as on average R2-fold up in WT bulge versus WT HG
(4,453 probes) and R2-fold up in WT HG versus WT bulge (2,555 probes)
were defined as bulge and HG signature genes, respectively. The matrix
signature genes were defined as R2-fold up in anagen matrix versus
anagen bulge and telogen bulge, utilizing previously published databases
(Lien et al., 2011).
Immunofluorescence Staining
The frozen-cut skin sections were incubated with primary antibodies in
the blocking solution for 1–4 hr at room temperature or overnight at 4C
with following dilution: rabbit anti-Runx1 (1:4,000; a gift from Thomas Jessell),
mouse anti-Myc tag (1:200; Zymed), rat anti-CD34 (1:50; BD Biosciences),
rabbit anti-K5 or K14 (1:1,000; Covance), rabbit anti-activated caspase-3
(1:500; R&D Systems), mouse anti-AE13 (1:50; Immunoquest), mouse anti-
AE15 (1:10; a gift from Tung-Tien Sun), mouse anti-GATA3 (1:100; Santa
Cruz Biotechnology), rat anti-BrdU (1:300; Abcam), and rabbit anti-Ki67
(1:1,000; NovoCastra Laboratories). This was followed by incubation in
secondary antibody fluorescently coupled with fluorescein isothiocyanate or
Texas red.
Microscopy and Image Processing
We examined all stained samples under a fluorescent upright light
microscope (Nikon). Images were obtained with a charge-coupled device
12-bit camera (Retiga EXi; QImaging) using the IP-Lab software (MVI),
color combined, and assembled in montages. All the images were pro-
cessed with Photoshop and Illustrator (Adobe) to enhance the contrast,
brightness, and levels to the same extent among samples within the same
experiment.
Cell Culture and Colony Formation Assay
Two hundred thousand live skins isolated in sterile conditions from adult mice
were plated onto the embryonic feeder cell layers in low-Ca2+ keratinocyte
E medium (Barrandon and Green, 1987). To maintain Runx1 expression,
0.5 mg of doxy/ml of media was added to cultures. The number of colonies
was counted by phase-contrast microscopy every 5 days during the first
30 days and every 7 days during the last 30 days.
See also Supplemental Information for additional details on the procedures.
ACCESSION NUMBERS
The GEO accession number for the data reported in his paper is GSE53077.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2013.12.039.
ACKNOWLEDGMENTS
We thank Y. V. Zhang and C. M. Piskun for experiments in Figures 2C and S2A
and many colleagues for reagents (see Experimental Procedures and Supple-
mental Information). The Cornell Cytometry core is supported in part by the
Empire State Stem Cell Foundation (ESSCF), New York State-Department of
Health (NYS-DOH), contract C026718. Opinions do not necessarily reflect
the view of ESSCF, the NYS-DOH, or NYS. Funding was from New York
Stem Cell Program C024354 and National Institutes of Health R01AR053201
to T.T. and Human Science Frontier to A.S. We thank colleagues, in particular
M. Rendl (Mount Sinai) for constructive criticism and V. Vogt (Cornell) for moral
support.
Received: August 16, 2013
Revised: October 31, 2013
Accepted: December 27, 2013
Published: January 23, 2014512 Cell Reports 6, 499–513, February 13, 2014 ª2014 The AuthorsREFERENCES
Barrandon, Y., and Green, H. (1987). Three clonal types of keratinocyte with
different capacities for multiplication. Proc. Natl. Acad. Sci. USA 84, 2302–
2306.
Blanpain, C. (2010). Stem cells: Skin regeneration and repair. Nature 464,
686–687.
Blyth, K., Cameron, E.R., andNeil, J.C. (2005). The RUNX genes: gain or loss of
function in cancer. Nat. Rev. Cancer 5, 376–387.
Ferrell, J.E., Jr. (2012). Bistability, bifurcations, and Waddington’s epigenetic
landscape. Curr. Biol. 22, R458–R466.
Greco, V., Chen, T., Rendl, M., Schober, M., Pasolli, H.A., Stokes, N., Dela
Cruz-Racelis, J., and Fuchs, E. (2009). A two-step mechanism for stem cell
activation during hair regeneration. Cell Stem Cell 4, 155–169.
Hoi, C.S., Lee, S.E., Lu, S.Y., McDermitt, D.J., Osorio, K.M., Piskun, C.M.,
Peters, R.M., Paus, R., and Tumbar, T. (2010). Runx1 directly promotes prolif-
eration of hair follicle stem cells and epithelial tumor formation in mouse skin.
Mol. Cell. Biol. 30, 2518–2536.
Hsu, Y.C., Pasolli, H.A., and Fuchs, E. (2011). Dynamics between stem cells,
niche, and progeny in the hair follicle. Cell 144, 92–105.
Ito, M., Kizawa, K., Hamada, K., and Cotsarelis, G. (2004). Hair follicle stem
cells in the lower bulge form the secondary germ, a biochemically distinct
but functionally equivalent progenitor cell population, at the termination of
catagen. Differentiation 72, 548–557.
Jaks, V., Kasper, M., and Toftga˚rd, R. (2010). The hair follicle-a stem cell zoo.
Exp. Cell Res. 316, 1422–1428.
Lee, J., and Tumbar, T. (2012). Hairy tale of signaling in hair follicle develop-
ment and cycling. Semin. Cell Dev. Biol. 23, 906–916.
Lee, J., Hoi, C.S., Lilja, K.C., White, B.S., Lee, S.E., Shalloway, D., and Tumbar,
T. (2013). Runx1 and p21 synergistically limit the extent of hair follicle stem cell
quiescence in vivo. Proc. Natl. Acad. Sci. USA 110, 4634–4639.
Lien, W.H., Guo, X., Polak, L., Lawton, L.N., Young, R.A., Zheng, D., and
Fuchs, E. (2011). Genome-wide maps of histone modifications unwind in vivo
chromatin states of the hair follicle lineage. Cell Stem Cell 9, 219–232.
Morris, R.J., Liu, Y., Marles, L., Yang, Z., Trempus, C., Li, S., Lin, J.S., Sawicki,
J.A., and Cotsarelis, G. (2004). Capturing and profiling adult hair follicle stem
cells. Nat. Biotechnol. 22, 411–417.
Mu¨ller-Ro¨ver, S., Handjiski, B., van der Veen, C., Eichmu¨ller, S., Foitzik, K.,
McKay, I.A., Stenn, K.S., and Paus, R. (2001). A comprehensive guide for
the accurate classification of murine hair follicles in distinct hair cycle stages.
J. Invest. Dermatol. 117, 3–15.
Nguyen, H., Rendl, M., and Fuchs, E. (2006). Tcf3 governs stem cell features
and represses cell fate determination in skin. Cell 127, 171–183.
North, T.E., de Bruijn, M.F., Stacy, T., Talebian, L., Lind, E., Robin, C., Binder,
M., Dzierzak, E., and Speck, N.A. (2002). Runx1 expression marks long-term
repopulating hematopoietic stem cells in the midgestation mouse embryo.
Immunity 16, 661–672.
Osorio, K.M., Lee, S.E., McDermitt, D.J., Waghmare, S.K., Zhang, Y.V., Woo,
H.N., and Tumbar, T. (2008). Runx1 modulates developmental, but not injury-
driven, hair follicle stem cell activation. Development 135, 1059–1068.
Osorio, K.M., Lilja, K.C., and Tumbar, T. (2011). Runx1 modulates adult hair
follicle stem cell emergence and maintenance from distinct embryonic skin
compartments. J. Cell Biol. 193, 235–250.
Porrello, E.R., Mahmoud, A.I., Simpson, E., Hill, J.A., Richardson, J.A., Olson,
E.N., and Sadek, H.A. (2011). Transient regenerative potential of the neonatal
mouse heart. Science 331, 1078–1080.
Pournasr, B., Khaloughi, K., Salekdeh, G.H., Totonchi, M., Shahbazi, E., and
Baharvand, H. (2011). Concise review: alchemy of biology: generating desired
cell types from abundant and accessible cells. Stem Cells 29, 1933–1941.
Rompolas, P., Mesa, K.R., and Greco, V. (2013). Spatial organization within a
niche as a determinant of stem-cell fate. Nature 502, 513–518.
Samokhvalov, I.M., Samokhvalova, N.I., and Nishikawa, S. (2007). Cell tracing
shows the contribution of the yolk sac to adult haematopoiesis. Nature 446,
1056–1061.
Scheitz, C.J., Lee, T.S., McDermitt, D.J., and Tumbar, T. (2012). Defining
a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer.
EMBO J. 31, 4124–4139.
Schwitalla, S., Fingerle, A.A., Cammareri, P., Nebelsiek, T., Go¨ktuna, S.I.,
Ziegler, P.K., Canli, O., Heijmans, J., Huels, D.J., Moreaux, G., et al. (2013).
Intestinal tumorigenesis initiated by dedifferentiation and acquisition of
stem-cell-like properties. Cell 152, 25–38.
Simons, B.D., and Clevers, H. (2011). Strategies for homeostatic stem cell self-
renewal in adult tissues. Cell 145, 851–862.
Spradling, A., Fuller, M.T., Braun, R.E., and Yoshida, S. (2011). Germline stem
cells. Cold Spring Harb. Perspect. Biol. 3, a002642.CTumbar, T., Guasch, G., Greco, V., Blanpain, C., Lowry, W.E., Rendl, M., and
Fuchs, E. (2004). Defining the epithelial stem cell niche in skin. Science 303,
359–363.
Waddington, C.H. (1957). The Strategy of the Gene (London: George Allen and
Unwin).
Yanger, K., Zong, Y., Maggs, L.R., Shapira, S.N., Maddipati, R., Aiello, N.M.,
Thung, S.N., Wells, R.G., Greenbaum, L.E., and Stanger, B.Z. (2013). Robust
cellular reprogramming occurs spontaneously during liver regeneration.
Genes Dev. 27, 719–724.
Zhang, Y.V., Cheong, J., Ciapurin, N., McDermitt, D.J., and Tumbar, T. (2009).
Distinct self-renewal and differentiation phases in the niche of infrequently
dividing hair follicle stem cells. Cell Stem Cell 5, 267–278.
Zhang, Y.V., White, B.S., Shalloway, D.I., and Tumbar, T. (2010). Stem cell
dynamics in mouse hair follicles: a story from cell division counting and single
cell lineage tracing. Cell Cycle 9, 1504–1510.ell Reports 6, 499–513, February 13, 2014 ª2014 The Authors 513
